GlassScriptPhysician profile
Eliza Sabo
NPI 1174363238
$1,408.03
in general payments reported to CMS, 2019-2025
16 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $191 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.30 | 2024-2025 | |
| Alkermes, INC. | $214.06 | 2024-2025 | Lybalvi, Aristada, Vivitrol |
| Axsome Therapeutics, INC. | $195.27 | 2024-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $93.21 | 2025 | Caplyta |
| Braeburn INC. | $92.94 | 2025 | Brixadi |
| Indivior INC. | $87.09 | 2025 | Sublocade |
| Vanda Pharmaceuticals INC. | $52.33 | 2025 | Fanapt |
| Almatica Pharma LLC | $43.45 | 2025 | Loreev Xr |
| Noven Therapeutics, LLC | $32.91 | 2025 | Xelstrym |
| Corium, LLC | $31.39 | 2025 | Azstarys |
| Janssen Pharmaceuticals, INC | $27.76 | 2025 | Spravato |
| Lundbeck LLC | $23.70 | 2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $22.31 | 2024 | Abilify Mycite |
| Biogen, INC. | $19.96 | 2025 | Zurzuvae |
| Orexo US, INC. | $17.50 | 2025 | Zubsolv |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $14.85 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliza Sabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.